Takeda to Buy Nycomed for 9.6 Bln Euros to Fill Sales Gap

The company, which traces its origins to a medicine wholesale business opened in Osaka in 1781, bought Millennium Pharmaceuticals Inc. for $8.9 billion in 2008. Nordic Capital, based in Stockholm, owns 41 percent of Nycomed, while Credit Suisse���s DLJ...